Finance Watch: No Big Post-ASCO Follow-On Frenzy, But Biotech Had A Good Week
SPAC On, SPAC Off As Anew Goes Public, Greenlight Goes Private
Public Company Edition: Follow-on offerings did not surge after ASCO, but Day One and Cogent raised $150m-plus. Also, IQVIA and Ionis sold $1.25bn and $500m in notes, while Krystal and Lexicon grossed $160m and $125m from post-approval offerings.
